Virtual 2020

Pre-Congress Content
Sunday, 06.09.2020
Monday, 07.09.2020
Tuesday, 08.09.2020
Wednesday, 09.09.2020


View the presentations you missed during Congress!

More than 1,100 webcasts and slide presentations, 3,500 e-posters and 4,000 abstracts from the Virtual Congress 2020 and are now available.

Citations should be made in the following way: Authors. Title. Eur Respir J 2020; 55: Suppl. 65, abstract number.

Optimal treatment for multistage N2-disease

Expert view
Aims: To determine the prognosis of patients with stage III NSCLC and ipsilateral lymph nodes; to differentiate among types of N2 disease; to describe the different treatment modalities (surgery plus chemotherapy; surgery, chemotherapy and radiotherapy; radiochemotherapy, and radiochemotherapy plus PD-L1 inhibition) and their advantages and disadvantages in specific situations; to assess the relevance of a multidisciplinary tumour board for these patients; and to describe future developments in immunology
The optimal treatment for multistage N2-disease
R. Huber (Munich, Germany)